The Safety and Efficacy of Angioseal in Therapeutic Endovascular Interventions

Aksoy, Murat; Becquemin, J. P.; Desgranges, Pascal; Allaire, Éric; Kobeiter, H.

doi:10.1016/j.ejvs.2005.12.014

Cited by 30 publications

(23 citation statements)

References 17 publications

(17 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The patient did not require interventional treatment [6]. Most of the studies report similar to ours frequency of local complications for the AngioSeal® device such as large subcutaneous haematoma, pseudoaneurysm, arteriovenous fistula, and limb ischaemia in comparison to the use of classic compression dressing [3,[12][13][14][15][16][17][18]. In one of the studies there was a tendency towards higher frequency of local complications in female patients, which was probably related to the lower diameter of the femoral artery in comparison to male patients [19].…”

Section: Discussionmentioning

confidence: 54%

“…The AngioSeal ® device was also not used in the case of a femoral artery bifurcation or a superficial/deep femoral artery puncture [3]. Importantly angiography of the femoral artery was performed in each case in our study prior to the AngioSeal ® use.…”

Section: Discussionmentioning

confidence: 99%

“…According to the AS instruction for use and pior reports we have avoided the use of the vascular closure device in the case of severly diseased arteries, especially when the vessel diameter was below 5 mm, if significant atherosclerotic lesions were localized within the distance of 5 mm from the puncture site or when they caused a 40% reduction of the vascular lumen (less advanced changes were a relative contraindication) [3]. The AngioSeal ® device was also not used in the case of a femoral artery bifurcation or a superficial/deep femoral artery puncture [3].…”

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

Control of local haemostasis with the AngioSeal® vascular closure device in peripheral endovascular interventions via 6-9 F femoral artery access

Machnik¹,

Pienia̦żek²,

Musiałek³

et al. 2012

pwki

View full text Add to dashboard Cite

A b s t r a c tBackground: Complications related to the femoral access substantially contribute to peri-procedural morbidity and mortality. Aim: To evaluate whether the use of a collagen plug as a vascular access closure device (AngioSeal ® , AS) influences complications related to the femoral access and duration of hospitalization for peripheral endovascular interventions.Material and methods: Two hundred and one consecutive patients (59.2% male, age 48-87 years) undergoing angioplasty/stenting of the internal carotid, common carotid, vertebral, subclavian, renal, iliac/femoral, innominate artery or cervical-subclavian bypass were randomized (1 : 1 ratio) prior to the intervention to standard manual compression (MC) or AS (6 F or 8 F device used for femoral access with 6-7 F or 8-9 F sheaths respectively).Results: Manual compression was used in 110 patients and AS in 91 patients. There was no difference in the use of 8-9 F and 6-7 F sheats between the two per treatment groups (72.5% vs. 73.6% and 27.5% vs. 26.2%, respectively). Large subcutaneous haematoma, arteriovenous fistula, pseudoaneurysm or femoral artery occlusion requiring surgery occurred in 13.8% MC vs. 4.0% AS for 6-7 F sheaths (p = 0.36) and in 19.7% MC vs. 7.6% AS for 8-9 F sheaths (p = 0.035). Total access site complication rate was 18.2% for MC and 6.6% for AS (p = 0.019). Nine patients with AS (9.9%) required an additional compression dressing (≤ 12 h). Overall, AS patients were mobilized earlier (2.9 ±2.4 h vs. 14.2 ±2.8 h, p = 0.001) and discharged home earlier after the intervention (33.6 ±14.16 h vs. 68.1 ±34.08 h, p = 0.001).Conclusions: The use of the AngioSeal ® device for femoral access closure during peripheral interventions (AngioSeal ® 8 F for 8-9 F sheath and AngioSeal ® 6 F for 6-7 F sheath) significantly reduces the access site complication rate and allows earlier patient mobilization and discharge from hospital.Key words: AngioSeal ® , vascular closure device, vascular access complications, femoral closure device S t r e s z c z e n i e Wstęp: Miejscowe powikłania dostępu naczyniowego przez tętnicę udową po zabiegach na tętnicach obwodowych istotnie zwięk-szają chorobowość okołozabiegową, wydłużają czas hospitalizacji oraz mogą się przyczyniać do zwiększonej śmiertelności okołoza-biegowej.Cel: Ocena skuteczności stosowania zapinek naczyniowych AngioSeal ® w redukcji liczby miejscowych powikłań dostępu naczyniowego, skracaniu czasu do uruchomienia i czasu hospitalizacji po przezskórnych interwencjach w naczyniach obwodowych.

show abstract

Section: Discussionmentioning

confidence: 54%

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Control of local haemostasis with the AngioSeal® vascular closure device in peripheral endovascular interventions via 6-9 F femoral artery access

Machnik¹,

Pienia̦żek²,

Musiałek³

et al. 2012

pwki

View full text Add to dashboard Cite

show abstract

“…1 Some studies showed the safety and efficacy of the device routinely used by our service, Angio-Seal®. 2,3 We have used so far 98 devices in 76 patients, with two previous episodes of complications similar to those reported herein.…”

Section: Discussionmentioning

confidence: 92%

Novas tecnologias, novas complicações: complicações após uso de novos dispositivos de selamento e de trombectomia arterial

Ferreira¹,

Monteiro²,

Abuhadba³

et al. 2007

J. vasc. bras.

View full text Add to dashboard Cite

We describe a singular case of both ischemic and traumatic complication, referring to use of new devices used for endovascular approach, in the same patient. One is a hemostatic closure device (Angio-Seal ® -St. Jude Medical) and the other is a catheter for percutaneous rotational and aspiration thrombectomy (Rotarex ® -Straub Medical). We discuss indication to use these devices in severely ill patients, with hemodynamic instability, or in a state of hypercoagulability, associated with femoral atherosclerotic disease, due to its high potential of complications.

show abstract

“…In surgery the material with a diameter of 0.5 × 1.5 cm was found and excised (Figs. [2][3][4]. Anterior wall of the superficial femoral artery was damaged because of collagenouse material and it was repaired with saphenous vein patch plasty.…”

mentioning

confidence: 99%

Intravascular misplacement of vascular closure device causing femoral artery obstruction

Şahin

Çelik

Güler

et al. 2011

International Journal of Cardiology

View full text Add to dashboard Cite

The Safety and Efficacy of Angioseal in Therapeutic Endovascular Interventions

Abstract: Angioseal provides a safe and effective way of closing the femoral artery puncture site with acceptable morbidity rates.

Cited by 30 publications

References 17 publications

Control of local haemostasis with the AngioSeal® vascular closure device in peripheral endovascular interventions via 6-9 F femoral artery access

Control of local haemostasis with the AngioSeal® vascular closure device in peripheral endovascular interventions via 6-9 F femoral artery access

Novas tecnologias, novas complicações: complicações após uso de novos dispositivos de selamento e de trombectomia arterial

Intravascular misplacement of vascular closure device causing femoral artery obstruction

Contact Info

Product

Resources

About